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Abstract
Background: Neural crest stem cells (NCSCs) are a transient multipotent embryonic cell population that represents a
defining characteristic of vertebrates. The neural crest (NC) gives rise to many derivatives including the neurons and glia of
the sensory and autonomic ganglia of the peripheral nervous system, enteric neurons and glia, melanocytes, and the
cartilaginous, bony and connective tissue of the craniofacial skeleton, cephalic neuroendocrine organs, and some heart
vessels.
Methodology/Principal Findings: We present evidence that neural crest (NC) competence can be acquired very early when
human embryonic stem cells (hESCs) are selectively neuralized towards dorsal neuroepithelium in the absence of feeder
cells in fully defined conditions. When hESC-derived neurospheres are plated on fibronectin, some cells emigrate onto the
substrate. These early migratory Neural Crest Stem Cells (emNCSCs) uniformly upregulate Sox10 and vimentin,
downregulate N-cadherin, and remodel F-actin, consistent with a transition from neuroepithelium to a mesenchymal NC
cell. Over 13% of emNCSCs upregulate CD73, a marker of mesenchymal lineage characteristic of cephalic NC and connexin
43, found on early migratory NC cells. We demonstrated that emNCSCs give rise in vitro to all NC lineages, are multipotent
on clonal level, and appropriately respond to developmental factors. We suggest that human emNCSC resemble cephalic
NC described in model organisms. Ex vivo emNCSCs can differentiate into neurons in Ret.k- mouse embryonic gut tissue
cultures and transplanted emNCSCs incorporate into NC-derived structures but not CNS tissues in chick embryos.
Conclusions/Significance: These findings will provide a framework for further studying early human NC development
including the epithelial to mesenchymal transition during NC delamination.
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Introduction
NCSCs have been well characterized in a number of model
organisms [1,2,3,4], including mouse, chicken, frog, and zebrafish
[5,6,7], but little is known about the mechanisms of human NC
specification, migration and differentiation.
In humans, the NC starts to migrate before neural tube closure,
as early as embryonic stage 9, around the third to fourth week of
pregnancy [8]. Multiple pathologies such as peripheral neuropa-
thies, skeletal and nervous system disorders and pigment disorders
stem from aberrant NC specification, migration or differentiation
[9,10,11]. The derivation of human NCSCs from human
embryonic stem cells (hESCs) will help to define the cellular and
molecular mechanisms operating in human cells and facilitate the
development of diagnostic and therapeutic strategies.
The manipulation of signaling molecules and pathways to
direct ESC differentiation has been widely reported in the
literature. Historically, the derivation of peripheral nervous
system (PNS) cell types from mouse and primate ESCs has relied
on co-culture with the mouse stromal line PA6 and late exposure
to BMP4 [12] or, in the case of hESCs, co-culture with PA6 [13].
Similar to the work reported here, NC derivatives were obtained
from bovine inner cell masses, after induction of differentiation
by withdrawal of growth factors and supplementation with
ascorbic acid [14]. NCSCs derived from hESCs after extensive
passages and/or using a combination of stromal induction and
the addition of BMP2 have been reported [15,16]. More
recently, the generation of a mixed population, depending on
the cell densities, of central nervous system (CNS) neural
progenitors and NC was also reported [17,18]. The obligatory
co-culture with PA6 or MS5 and the generation of only small
numbers of some NC lineages (sometimes requiring prospective
isolation of,0.1% of the cell population) are hurdles in all of the
current differentiation protocols. Additionally, because NC
competency is a transient phenomenon that appears to be
established very early during gastrulation [19], the possibility
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exists that extensive in vitro amplification alters the properties of
early NC cells.
We report that under conditions selectively promoting neur-
alization of hESCs towards dorsal neuroepithelial fate, NC
competence is acquired much earlier than previously possible.
Human ESC-derived NCSCs upregulate SoxE genes, Wnt and
TGFb signaling pathways associated with NC specification,
maintenance, and migration [20,21]. Using Sox10, a transcription
factor playing a critical role in NC development [22], we identified
a distinct population of Sox10-positive cells migrating from
adherent hESC-derived neurospheres. These emNCSCs can
differentiate into all NC lineages including PNS neurons and glia,
smooth muscle myocytes, chondrocytes and melanocytes and
respond to the well-known signals that block NC specification in
other model systems [23]. Migratory NCSCs can colonize
aganglionic embryonic gut cultures, where they differentiate into
neurons. Finally, grafting into chick embryos demonstrates that
hESC-derived emNCSCs contribute specifically to proper NC
derivatives, differentiating into neurons and glia in the cranial
ganglia, glia along nerves, mesenchyme and connective tissues in
cranial regions.
Methods
Culture of human ES cells
An NIH-approved commercially available human ES cell line
(H9, obtained from WiCell, Wisconsin) was used to generate
neural precursors/putative NC cells in vitro. Undifferentiated
hESCs were maintained on irradiated mouse feeder layers and
Matrigel (final dilution1:30; BD Biosciences, cat # 356231) in
Knockout DMEM (GibcoBRL/Invitrogen, cat #10829-018) with
20% Knockout Serum Replacement (GibcoBRL/Invitrogen, cat
#10828-028), non-essential amino acids (100 mM final; Gib-
coBRL/Invitrogen, cat #11140-050), L-glutamine (final 1 mM;
GibcoBRL/Invitrogen, cat #25030-081), b mercaptoethanol
(100 mM final; GibcoBRL/Invitrogen, cat #21985-023), and
supplemented with bFGF (final 8 ng/ml; Sigma, cat# F -0291-
25UG). hESCs were passaged every 7-10 days by separating cells
manually or using collagenase IV (final 1 mg/ml; GibcoBRL/
Invitrogen, cat #17104-019) diluted in KO DMEM. Medium was
changed every day and differentiating colonies were manually
removed.
Generation of emNCSC from human ESCs
The differentiation protocol was previously described [24],
except that day 5 spheres were plated on fibronectin. Briefly,
collagenase IV passaged cells were resuspended in PBS and large
clusters, not appropriate for neurosphere formation, were gravity
pelleted and discarded. Clusters of hESCs that were left in
suspension (about 50-100 cells/cluster) were transferred to a new
tube, gravity pelleted and washed with PBS one additional time to
remove all residual media and single cells. Cells were resuspended
in neurosphere suspension (NS) medium: 1:1 ratio of DMEM/F-
12 Glutamax (GibcoBRL/Invitrogen, cat# 10829-018) and
Neurobasal media (GibcoBRL/Invitrogen, cat# 11140-050),
BIT 9500 (final 10%; StemCell Technologies Inc, cat# 09500),
L-glutamine (final 1 mM; GibcoBRL/Invitrogen, cat# 25030-
081),50 U/ml penicillin, 50 mg/ml streptomycin (Invitrogen,
cat#15070-063), ) and B27 (final 5%; GibcoBRL/Invitrogen,
cat# 17504-044) supplemented with insulin (final 5 ng/ml; Sigma,
cat# I4011), nicotinamide (final 5 mM; Sigma, cat# N0636)
supplemented with bFGF (final 20 ng/ml; Chemicon, cat#
GF003) and EGF (final 20 ng/ml; Sigma, cat# E9644). Neuro-
spheres were cultured for 5 days in non-adherent polypropylene
dishes (Ted Pella, Redding, CA), changing the media every 2 days.
Day 5 neurospheres were plated on fibronectin-coated (final
1 mg/ml) culture dishes in NS medium. EmNCSCs were passaged
every 3–4 days with Accutase.
Illumina Microarray and Q-PCR analysis
Total RNA was extracted using the RNeasy kit and 1 mg of total
RNA was reverse transcribed using the Quantitect kit (Qiagen)
according to the manufacturer’s suggestions. About 500 ng total
RNA per time point was used for cDNA synthesis followed by
cRNA synthesis/amplification and labeling using the ‘‘Illumina
RNA amplification’’ kit (Ambion). The labeled cRNA was
hybridized to Human WG-6 sentrix BeadChip Arrays (Illumina)
and scanned following the manufacturer’s instructions. Analysis
was performed using the algorithms included with the GeneSpring
software. Gene expression changes greater than 2-fold; parametric
test, variance equal, P value cut off = 0.05; Volcano statistic
analysis GeneSpring software were considered significant. For Q-
PCR, GAPDH was used for normalization and the data were
analyzed using the standard curve method. Microarray and Q-
PCR were processed by the Burnham Institute’s gene analysis core
facility. Q-PCR was performed with SyberGreen master mix
(Invitrogen) according to the manufacturer’s recommendation.
Primer sequences are provided in Table 1. Q-PCR was perfomed
as follows: Initial denaturation: 10 min at 95uC; 40 cycles of
denaturation: 30 sec at 95uC, annealing: 1 min at 56uC,
extension: 30 sec at 72uC; and one final cycle of denaturation
for 1 min at 95uC, annealing for 30 sec at 65uC and final
denaturation for 30 sec at 95uC. Microarray hybridizations were
performed on Illumina arrays and analyzed with Genespring
software. All data are MIAME compliant and that the raw data
has been deposited in a MIAME compliant database (GEO,
accession number #pending).
Immunohistochemistry
Cells were fixed with 4% paraformaldehyde in PBS for 15
minutes at room temperature and rinsed 3 times with PBS.
Following fixation, cells were blocked in 3% BSA or 10% goat
serum for 10 minutes, primary antibodies (Table 2) diluted in 3%
BSA/PBS or 10% goat serum/PBS were then applied at the
appropriate concentration and incubated either at room temper-
ature for 1 hour or overnight at 4uC. Cells were then washed 3
times for 3 minutes, and incubated at room temperature with an
appropriate fluorochrome-conjugated secondary antibody (1:1000
diluted in 3% BSA/PBS). Cells were washed 3 times for 5 minutes
and incubated for 10 minutes with Hoechst dye #33342 or Dapi
to label cell nuclei.
Table 1. Primers used for Q-PCR of PAX3.
NCSC Q-PCR
Pax3-F GCATGTTCAGCTGGAAATC
Pax3-R ATGCTGTGTTTGGCCTTCTT
GAFP-F TCCTGGAACAGCAAAACAAGG
GFAP-R GTAGTCGTTGGCTTCGTGCTT
GAPDH F GAAGGTGAAGGTCGGAGTC
GAPDH R ATGGGATTTCCATTGATGAC
doi:10.1371/journal.pone.0013890.t001
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Clonal expansion of emNCSCs and lineage analysis
Clonal analysis was performed as described by the Studer
group[15]. Briefly, cells were enzymatically dissociated after
exposure to Accutase for 10 min. The cells were sedimented by
centrifugationand the pellet was resuspended and filtered through
40 mm mesh. Filtered cells were counted and directly plated onto
polyornithine (1.6 mg/ml ) + fibronectin (2 mg/ml) coated dishes
at clonal densities (,10 cells/cm2). Cells were grown in NS
medium for 15 days followed by mitogen (bFGF and EGF)
withdrawal and culture in NS medium supplemented with BDNF
(10 ng/ml), NGF (10 ng/ml), GDNF (10 ng/ml), 1 mM dibutyryl
cAMP, CNTF (10 ng/ml) and neuregulin (20 ng/ml) for 15 days.
Cell were fixed in 4% paraformaldehyde for 10 minutes at room
temperature and incubated with primary antibody overnight at
4uC, followed by 1 hour incubation with the secondary antibodies
at room temperature.
Addition of exogenous factors to manipulate NC
specification or migration
BMPs, Wnts and retinoic acid have all been found to play roles
in the specification and migration of NC in model organisms
[20,23,25]. Neurospheres were cultured (suspended for 5 days with
3 days of adherent culture) in NS medium in the presence of
100 ng/ml Noggin (a BMP antagonist) or a conditioned medium
from DKK1-producing 293T cells. Adherent cultures were then
stained with the NC markers Sox10, p75 or HNK-1.
In vitro derivation of NC-derived lineages and directed
differentiations
For spontaneous differentiation, emNCSCs were maintained at
confluency for up to 3 weeks in NS medium. Basic NS medium
(NS medium without EGF, FGF, insulin or nicotinamide) was
modified as previously described for directed differentiation
[26,27,28,29]; Briefly, for neuronal differentiation, 50 ng/ml
BMP2 (R&D Biosystems), for neuroglial, 10% FCS/5 mM
Forskolin (Sigma) and for smooth muscle myocytes 1 ng/ml
TGFb3 (R&D Biosystems) were supplemented to NS basic
medium. To induce chondrogenic differentiation, 16106
emNCSCs were centrifuged at 8006g for 3 min. Pelleted cells
were fed with chondrogenic medium (Lonza) supplemented with
10 ng/ml TGFb3 (USBiological). Medium was changed every
third day. Cultures were fixed after 4 weeks and chondrogenic
differentiation was assessed by immunohistochemistry (Alcian
blue).
Prospective isolation by Fluorescence Activated Cell
Sorting
At day 9 of emNCSC derivation the adherent neurospheres
(composed of neuroepithelial rosettes) were mechanically removed
and putative migrating emNCSCs were detached with Accutase
and resuspended in 3% BSA/PBS for 20 minutes to block non-
specific binding. Cells were then incubated with p75 (1:300),
HNK-1 (1:300) or CD73 (1:500) for 30 minutes. Cells were
washed in 3 ml of PBS and resuspended in 3% BSA/PBS with
appropriate secondary antibodies (1:1000) for 30 minutes and
washed with 3 mls of PBS before being resuspended in 1% BSA/
PBS and incubated with PI (live/dead stain). Cells were sorted
according to fluorescence (FACSVantageSE DiVa, BD Bioscienc-
es, San Jose) and data were analyzed with FlowJo (version 8)
software.
Injection of emNCSCs into organotypic fetal gut cultures
The intestine was isolated from day 10.5-11 Ret.k- embryos.
Mice carrying the Ret.k- mutation were previously characterized
and analysis of homozygous embryos has demonstrated that the
aganglionic phenotype is due to an early defect of the enteric NC
[30]. The method for organotypic embryonic gut cultures was
previously described [31]. Briefly, E10.5- 11 Ret.k- mouse embryos
were obtained from timed pregnant heterozygous matings. The
developing gut was dissected and placed across a V-shaped notch
cut into Millipore paper (0.45 mm, Black gridded type HAGB,
Millipore, Bedford MA). Each gut segment suspended on filter
paper was placed into a Tersasaki well (60-well plate, Disposable
Products, Technology Park, SA, Australia) overfilled with media to
cover the entire gut segment and cultured in 5% CO2 at 37u for 7
days. EmNCSCs were injected into the intestinal lumen and walls
using a fire-polished glass needle connected to a mouth-injection
tube. On average, 16105 cells were injected per gut piece. After 7
days, gut cultures were used for whole mount immunostaining and
cryosectioning. Whole mount immunostaining for neurofilament
was performed as previously described [32]. The Ret.k mice were
housed in accordance with NIH guidelines and the Burnham
Institute animal house rules.
In ovo transplantation. Fertile chicken eggs were incubated
until somite stage 7 to 12. Eggs were windowed and embryos
visualized using India Ink (1:10). Pelleted emNCSCs (,10,000
cells) were injected beside the cranial neural tube, in the pathway
of migratory NC. Eggs were sealed and incubated for 1–5 days, at
which time the embryos were fixed and cryosectioned [33].
Sections were incubated overnight with antibodies raised against:
human nuclei (mouse IgG1, Chemicon MAB1281, 1:250), early
neuronal marker HuC/HuD (mouse IgG2b, Invitrogen A-21271,
1:250 [34]) and HNK-1 (mouse IgM, DSHB, 1:100) and smooth
muscle actin (mouse IgG2a, Sigma A2547, 1:800). Sections were
then washed and incubated in conjugated secondary goat anti-
mouse antibodies (all from Invitrogen): IgG1 Alexa 488, IgG2a
Alexa 594 (both 1:2000), IgG2b Alexa 633 and IgM Alexa 350
Table 2. Antibody purchasing and dilution information.
p75 Alomone Labs Rabbit 1:200 IF/1:300 facs
Sox10 M. Wegner Mouse Undiluted
HNK-1 M. Fukuda Mouse 1:30 IF
Map2 Sigma Mouse 1:500
GFAP Chemicon Rabbit Pre-diluted
SMA Sigma Mouse 1:500-1:800
TH Chemicon Chicken 1:100
Peripherin Chemicon Rabbit 1:1000
BRN 3a Chemicon Rabbit 1:100
Ki67 Novocastra Rabbit 1:500
CD73 BD Mouse 1:500
Nestin Chemicon Mouse 1:500
HuNU AG Chemicon Mouse 1:250
HuC/HuD Invitrogen Mouse 1:250
HNK-1 (in ovo) DSHB Mouse 1:100
Neurofilament DSHB Mouse 1:50
PLP AVES Labs Chicken 1:50
Pax6 Chemicon Rabbit 1:500
Pax3 Zymed Rabbit 1:200
Sox9 Chemicon Rabbit 1:200
doi:10.1371/journal.pone.0013890.t002
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(both 1:1000). Sections were imaged using Zeiss Axioskop plus
microscope with AxioVision 4.6 software.
Results
Derivation of human emNCSC from hES cells
hESCs can be efficiently differentiated into uniform neural
progenitors, as previously shown [24]. Around day 5 of
differentiation, rosette structures appeared within floating neuro-
spheres that resemble primitive neuroepithelium and are reminis-
cent of neural tubes [14,35]. The cells were collected and the
dorsal – ventral identity of the cells was investigated (Figure 1). At
this time of differentiation, most cells were positive for the pan-
neuroepithelium marker Pax6 as well as dorsal neuroepithelial
markers Pax3 and Sox9 but negative for the ventral neural tube
marker Nkx2.2. The Q-PCR analysis was consistent with the
immunostaining data. These results suggest that current neur-
alization conditions (see methods and expression analysis below)
favor the derivation of dorsal neuroepithelium, which is the region
of the neural tube from which NC arises in vivo [36,37].
Primary murine NC cells are typically derived by plating neural
tube explants from embryonic day 8.5 on fibronectin (a substrate
permissive of NC migration in vivo [38]) and recovering the
migrating cells [27]. Therefore, we plated day 5 neurospheres
containing rosette structures on fibronectin and assayed NC
marker expression after several days of migration. We found that 3
days of exposure to fibronectin resulted in a high number of
migratory cells, which we called early migratory NCSCs. These
cells express the NCSC markers Sox10, p75 and HNK-1
(Figure 2). The emNCSCs were uniformly positive for Sox10,
while attached neurospheres composed of neuroepithelial rosettes
(Figure 2D) were uniformly negative for Sox10 (Figure 2B, E). In
contrast, both attached neurospheres and migrating cells were
heterogeneously positive for the classical NC markers p75 and
HNK-1 (Figure 2C, E, G). Because the adherent neurospheres
resemble dorsal neuroepithelium, this observation appears similar
to the in vivo situation. Indeed, in mouse embryos (E9.5-E11) at
least some cells in the dorsal neuroepithelium (premigratory NC)
are positive for the p75 marker [39] and human neural tube
explants were reported to express p75 [40]. After an initial wave of
NC emigration the adherent neurospheres (uniformly negative for
Sox10) were scraped off the plate and replated. A second wave of
emigrating cells was observed, which also acquired the Sox10 and
p75 markers (Figure 2G–H). Most cells within the replated
neurospheres remained Sox10-negative and the secondary wave of
emigrating cells appeared to have higher levels of the p75 marker.
These results suggest that many, if not all, cells within the adherent
spheres are competent to upregulate Sox10 upon delaminating
from neuroepithelial clusters and initiating migration on fibronec-
tin. This behavior is reminiscent of an epithelial to mesenchymal
transition (EMT), a characteristic feature of NC cells in model
organisms [41].
Emigration of emNCSCs from neuroepithelial clusters
resembles EMT
Adherent neurospheres display thick bands of f-actin at the cell
borders, characteristic of epithelial cells. Cells migrating from
neurospheres acquire vimentin expression (Figure 3C–D) and
have thin bands of f-actin at the cell borders and diffuse f-actin
Figure 1. Neuralized human ES cell-derived express markers of dorsal neuroepithelium. hESCs were neuralized for 5 days in floating
spheres, dissociated and cytospins were immunostained for Pax6 (A), Sox9 (B), Pax3 (C), and Nkx2.2 (D). (E) Quantification of the results in A–D. (F) Q-
PCR analysis of Sox9 and NKX2.2 expression in day 5 spheres (black bars) vs hESC (white bars). All values normalized to 18S expression; * = p,0.05,
** = p,0.0001, one-tail unpaired t-test. Scale bars 50 mM.
doi:10.1371/journal.pone.0013890.g001
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expression throughout the cell body (Figure 3A–B), consistent
with observations in mesenchymal cells [42]. This alteration of
the f-actin distribution between the rosette cells and the
migrating cells is reminiscent of the EMT observed in NC cells
delaminating from the neural tube in vivo [41]. Similarly, the
adherent neurospheres are positive for N-cadherin and
emNCSCs downregulate N-cadherin expression, in further
support of an EMT [43]. In addition, emNCSCs upregulate
the expression of gap junction protein connexin 43 (Cx43) at the
onset of migration (Figure 3F). The expression of Cx43 was found
to be critical for NC cell survival and characteristic of early
migratory NC cells in vivo [44]. In summary, the transition from
adherent neurospheres (further referred to as neuroepithelial
clusters) to migratory Sox10-positive cells has many features of
classical EMT observed during delamination of NC in vivo in
model organisms.
Microarray analysis of neuroepithelial clusters and
migratory NCSC
The above results provide some distinctions between the Sox10-
positive cells in neuroepithelial clusters and the Sox10-positive
migratory cells. To further investigate the molecular difference
between the two populations, we mechanically separated adherent
neurospheres from migratory cells and performed microarray
analysis of gene expression (Figure 4). We found that in migratory
cells, 84 genes were significantly upregulated and 103 were
downregulated compared to the neuroepithelial clusters. Con-
firming the immunostaining data, the SOX10 transcript was
upregulated in migratory cells. Several well-known regulators of
the NC lineage were selectively upregulated in migratory cells (e.g.,
PhOX2b, RGS 4, HEY1, DLK1, and GnRH2). Several other NC
genes such as FOXD3, MSX1, PITX1, and Hand1 were upregulated
in migratory cells. Curiously, IGFBP5, a negative regulator of NC
Figure 2. Early migratory NCSCs upregulate Sox10. Immunostaining of adherent neurospheres and emigrating NCSCs after 3 days on
fibronectin-coated plates. (A) DAPI staining for nuclei. Note the rosette structures within the adherent neurospheres. (B) Sox10 staining is observed in
emigrating cells, but not in the adherent neurospheres. (C) p75 staining is observed in adherent neurospheres and emigrating cells. (D) High
magnification of the overlay in B–C. (E) Confocal image of emigrating NCSCs confirms the membrane localization of p75. (F) HNK-1 staining is
observed in adherent neurospheres and emigrating cells. (G, H) Adherent neurospheres were manually removed and replated on fibronectin and the
second wave of emigrating cells was observed. (G) Secondary emigrating cells acquire Sox10, while the majority of cells in the replated neurosphere
are Sox10-negative. (H) The expression of in the second wave of emigrating cells. Scale bars in A, B, C and D represent 100 mm and 10 mm in E Bars in
F,G and H depict 150 mm.
doi:10.1371/journal.pone.0013890.g002
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and a potential regulator of craniofacial skeletogenesis [45], was
selectively downregulated in migratory cells, suggesting a potential
interaction between the neuroepithelial clusters and emigrating
cells.
In addition to the expression analysis described above, we
determined the dynamic expression of key NC-related genes over
10 days of neuralization using the entire cultures (Figure S1).
Among the upregulated transcripts were the growth factors Wnt3a
(2-fold at 72 hours),Wnt1 (2-fold at 96 hours) and BMP4 (2-fold by
day 3) as well as the downstream transcription factors Sox9 (2-fold
at day 3), Sox10 (7-fold day 6), ZIC1 (2-fold at day 3), MSX1 (2-fold
by day 2) and SNAIL, (2-fold by 60 hours). In addition, we used Q-
PCR to examine the expression of Pax3, one of the earliest gene
defining the NC field [46]. PAX3 transcripts were found to be
upregulated 2-fold at day 3 and 10-fold at day 5 of hESC
neuralization.
We demonstrated a dynamic regulation of most NC-related
genes during hESC differentiation towards emNCSC, including
the upregulation of many NC-related genes in emNCSC when
compared to the neuroepithelial clusters. These data contribute to
our understanding of gene regulatory network orchestrating neural
crest formation and provide support to our interpretation of the in
vitro human model system - the cells within the clusters are similar
to the dorsal neuroepithelium, while emigrating cells resemble
NCSCs.
p75 expression does not discriminate emNCSCs from
neuroepithelial clusters
Previously, the p75 marker was used for prospective isolation of
NCSCs from rat embryo sciatic nerves [1] and when differentiated
from hESCs after prolonged differentiation on stromal feeders
[15]. We found that the membrane-specific immunostaining for
p75 was present in both clusters and emigrating cells (Figure 2C–
E). We employed flow cytometry to prospectively isolate cells from
hESC neuralization cultures at day 8, based on p75 expression.
Consistent with the immunostaining data, most cells were positive
for p75 (Figure 5A). Cells expressing high, medium, and low levels
of p75 were isolated by FACS and their Sox10 levels and
differentiation potential were examined (Figure 5). Most cells,
whether p75 high, medium, or low, expressed Sox10 (85%, 80%,
and 90% respectively, Figure 5B). After one week of spontaneous
differentiation on fibronectin young neurons (bIII-tubulin), glia
(GFAP), smooth muscle cells (SMA), as well as undifferentiated
cells (nestin) were found in all cultures (Figure 5C and data not
shown). No selectivity for differentiation into any particular lineage
could be detected in the three populations. Another marker,
HNK-1, was previously proposed as a marker of NC in chick
embryos [47] and was used in the hESC system [15]. Flow
cytometry analysis of day 8 cultures revealed that over 90% of cells
are positive for the HNK-1 marker (data not shown). These results
suggest that the p75 and HNK-1 markers, previously used to
prospectively isolate human NCSCs after prolonged differentiation
on stromal feeders [15] are ineffective in discriminating migratory
cells from the neuroepithelial clusters in our cultures. Because
many (if not all) cells in the clusters can give rise to the migratory
Sox10+ cells (e.g. when re-plated on fibronectin) it is possible that
these pre-migratory NC cells already upregulated the p75 and
HNK1 molecules.
Differentiation of emNCSC into the NC lineages
We determined whether emNCSCs as a population were able to
give rise to a variety of NC lineages found in vivo, including
Figure 3. Epithelial to mesenchymal transition in migratory emNCSCs. (A) Phalloidin stains thick bands of f-actin within the adherent Sox10-
negative neurosphere and thin cell border bands. Diffuse f-actin staining is visible in migratory Sox10-positive cells. (B) Connexin 43 (red) is acquired
in migratory emNCSCs. Attached sphere is outlined. (C) N-Cadherin (green) is present in adherent neurospheres and gradually downregulated in
migratory emNCSCs visualized by the nuclear DAPI IHC. (D) Confocal image of thick f-actin (red) bands at the border of an adherent neurosphere
(outlined). Vimentin (green) is acquired in emNCSCs migrating away from the attached neurosphere. Scal bars in A and B represent 50 mm, in C
25 mm, and in D 10 mm. Cell nuclei were visualized by DAPI unless indicated differently.
doi:10.1371/journal.pone.0013890.g003
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neurons, glial or mesenchymal lineages, melanocytes, and
adipocites. EmNCSCs were allowed to spontaneously differentiate
in dense cultures through contact inhibition and were assayed for
NC derivatives after 2–3 weeks (Figure 6 and Figure S2). After ,2
weeks in culture, peripheral autonomic lineages were identified by
co-staining of TH and peripherin [48] (Figure 6A) and sensory
peripheral lineages were detected by BRN3a (premigratory crest
and neurons of the DRG) reactivity (Figure 6B). Neuronal
derivatives were found to comprise 30% 610% of derivatives.
Myocytes were identified by smooth muscle actin staining after
one week in culture (Figure 6C), and were also observed to
comprise approximately 30% 610% of derivatives. Consistent
with events during normal developmental and in agreement with
the previous observations [15], neurogenesis preceded gliogenesis.
Characteristic markers of Schwann cells could be detected in
cultures after emNCSCs were passaged for 3–4 weeks and
differentiated for additional two weeks (Figure 6D). Glial
derivatives comprised 20% 610% of total derivatives. Melano-
cytes (comprising 5% 63% of derivatives) were observed after 3-4
weeks in culture. Melanocytes were identified by their character-
istic black melanosome inclusions and Melan A reactivity
(Figure 6E).
Previously, NCSCs were observed to respond to various
combinations of factors, selectively generating specific NC lineages
[15,26,49]. The addition of single growth factors to NS basal
medium (no growth factors) led to enrichment of distinct cell types
in the cultures. Addition of TGFb initiated mainly two cell types:
neurons and myocytes at a ratio of 70% 65%: 28% 64%
(Figure 7A–D, TGFb). To enrich for neuro-glial precursors, 10%
fetal calf serum and forskolin (5 mM) were added to NS base
medium. Under these conditions, glia comprised 30% 62% of the
cells, neuronal markers were detected in 60% 65% of the cultures
Figure 4. Microarray analysis of the adherent neurospheres and emNCSCs. The top most upregulated gene transcripts in emNCSCs (red)
and neuroepithelial clusters (blue) are shown. The middle insert highlights the selected set of NC-related genes upregulated in emNCSCs.
doi:10.1371/journal.pone.0013890.g004
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and no SMA-positive cells were detected (Figure 7E–H, FCS/
Forskolin). Culturing emNCSCs with BMP2 enriched for a
neuronal phenotype (Figure 7I–L, BMP2). Fifty percent 67% of
cells were positive for b III tubulin. Five percent 62% were
positive for GFAP, indicating glial differentiation and another
40% 63% stained positive for SMA, indicative of myocyte
differentiation. For chondrocytic differentiation, emNCSCs were
incubated in defined medium, in a high-density culture, under
low-oxygen conditions for 4 weeks [27]. Comparable to data
published earlier, this method resulted in cell aggregates that when
sectioned, showed strong expression of collagen in the intercellular
space as shown by Alcian blue staining (Figure 7M and N).
Figure 5. p75 expression doesn’t discriminate emNCSCs from neuroepithelial clusters. (A) Day 8 cultures (containing emNCSC and
neuroepithelial clusters) can be FACS-sorted based on p75 expression defining three populations: negative, medium and highly positive for p75. The
grey profile corresponds to control situation with the secondary antibody only. (B) All fractions of cells were positive for Sox10 (85, 70 and 60%
respectively for high, medium and negative). (C) All fractions can differentiate into neuronal, glial and smooth muscle lineages (p75-negative fraction
is shown as an example). p75-negative sorted cells are reactive for; I. GFAP, II. b-3-tubulin, III. nestin, IV. smooth muscle actin. Cell nuclei are
visualized by DAPI. Magnifications are 100x. Scale bars 30 mM.
doi:10.1371/journal.pone.0013890.g005
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In summary, spontaneous and directed differentiation of human
emNCSCs in vitro into multiple NC-specific lineages demonstrates
their broad potential and ability to respond appropriately to
developmental cues.
Clonal expansion of emNCSCs and lineage analysis
Experiments in model organisms suggested that in vivo, NC cells
include multipotent, oligopotent and unipotent clones [50,51]. In
order to assess the differentiation potential of emNCSCs at a single
cell level, we performed clonal analysis experiments by plating single
cell dissociated emNCSCs at clonal densities as previously described by
the Studer group[15]. Staining of 20 clones for markers of neurons
(TuJ1), glial cells (GFAP) and smooth muscle cells (SMA) revealed 12
clones (63%) positive for all three lineage markers, 3 clones (16%)
positive for TuJ1 and GFAP, 3 clones (16%) positive for SMA only,
and 1 clone (5%) positive for TuJ1 only (Figure 8). These results
suggest that emNCSCs are multipotent on the clonal level.
Inhibition of BMP and Wnt signaling re-specifies
emNCSCs into CNS cells
Exogenous factors, such as BMPs and Wnts are well-known
modulators of NC specification and migration in vivo [20,23,52].
BMP4 is expressed in the avian dorsal neural tube at the time of
neural tube closure when NC migration starts. Addition of Noggin
at this stage, but not at later stages, inhibits NC formation and
migration [23]. We tested the effect of Noggin on the derivation of
emNCSCs from hESCs. Control cells show Sox10, HNK-1 and
p75 reactivity (Figure 9A–C). The addition of Noggin (100 ng/ml,
starting on day 0, medium was changed every other day) nearly
ablated expression of the NC markers Sox10, p75 and HNK-1
(Figure 9D–F). At the same time, the migration of cells from each
adherent neurosphere was less than in controls (70% of control,
Figure 9J). Similarly, the addition of the Wnt/b-catenin antagonist
Dkk1 ablated expression of the NC markers Sox10 and HNK-1,
but not the low affinity neurotrophin receptor p75. The retention
of p75 is consistent with the finding that Wnt signaling does not
change the axial identity of cells in the developing neural tube, but
rather re-specifies the cell fates at the early stages of NC
development [53]. These results indicate that human emNCSCs
appropriately respond to the stage-specific developmental signals,
consistent with the early migratory nature of the emNCSCs
identified in this study.
Mesenchymal potential of emNCSCs
In vivo, early migratory NC cells (i.e. cephalic NC) are
considered a uniform population of cells, capable of differentiation
into mesenchymal lineage (e.g., myocytes) and peripheral neurons
and glia [51,54]. In a previous study, human ESC-derived NCSCs
were found to contain a small population of mesenchymal
precursors, identified by the CD73 marker [15]. We examined
CD73 expression in day 5 neurospheres prior to culturing on
fibronectin, as well as in epithelial clusters and migratory cells 3
days post plating on fibronectin. The day 5 neurospheres displayed
no CD73 as expected for undifferentiated cells of neural origin
(Figure 10A). At day 8 post plating, neuroepithelial clusters were
also negative for CD73, however, ,13% of the migrating
emNCSCs were positive for CD73 (Figure 10B–C). To investigate
their differentiation potential, CD73-positive and -negative
populations were isolated by FACS. Both populations were
allowed to differentiate for one week after sorting and assayed
for SMA, nestin, MAP2 and Ki67 markers. Both CD73-positive
and -negative sorted cells gave rise to abundant SMA+ and nestin+
cells. GFAP+ cells were rare in both cases; however, CD73-
negative cells produced approximately 10-fold more MAP2-
positive cells than the CD73-positive fraction (Figure 10D). These
data suggest that CD73-positive cells are much less efficient at
differentiation into the neuronal lineage, as expected for the
mesenchymal component of NC. Further experiments are needed,
however, to demonstrate the selective advantage CD73-postive
cells for mesenchymal differentiation.
Injection of emNCSCs into organotypic embryonic gut
cultures
The ability of emNCSCs to colonize and differentiate into
appropriate NC derivatives in a disease model was tested by
injection of emNCSCs into aganglionic embryonic gut cultures
derived from mice carrying Ret.k- mutation. As previously
described, only NC-derived enteric neurons can repopulate the
Ret.k- intestine [31]. Undifferentiated emNCSCs derived from
hESC engineered to express GFP were injected into the knockout
gut segments. After 7 days of culture, the tissue was cryopreserved,
sectioned and immunostained for GFP and neurofilament.
emNCSCs integrated into the Ret.k- intestinal wall and differen-
tiated into neurons within the 7 days of culturing (Figure 11A).
Because Ret.k- embryos totally lack the enteric nervous system in
the small and large intestine [31], neurofilament-positive cells must
be derived from injected human emNCSCs. Indeed, no staining
Figure 6. Spontaneous differentiation of emNCSCs. (A) Periph-
eral neuron-like cells are co-stained with TH (green) and Peripherin
(red). Individual channels are shown in the inserts.(B) Smooth muscle
cells reactive to smooth muscle actin. (C) The addition of 1% horse
serum to the NS medium yielded GFAP-positive cells co-expressing
p75NTR and proteolipid protein (PLP), consistent with Schwann cell
identity. Inset, PCR detection of GFAP transcript. CTRL = NS medium.
Scale bar = 25 ı`m. (D) Brn3a (red) and Peripherin (green) staining
indicates differentiation into peripheral sensory-like neurons. (E) Bright
field image of black inclusion bodies in a characteristic melanosome,
inset box shows Melan A (green) reactivity. Nuclei were visualized by
DAPI. Scale bars represent 40 mm in A, C and D, 60 mm in D, and
100 mm in E and its inset.
doi:10.1371/journal.pone.0013890.g006
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for neurofilament was detected in the non-injected gut segments
(Figure 11B). The endogenous enteric neurons were detected in
the heterozygous animals (Figure 11C). The Ret.k- animals are
unable to generate enteric neurons [31]. However, the Ret.k-
intestines injected with human emNCSC show immunostaining
for both GFP and neurofilament, likely due to the generation of
neurofilament+ cells from human emNCSC (Figure 11D). These
data suggest that emNCSCs are able to colonizing the Ret.k- gut
Figure 7. Directed differentiation of emNCSCs. The growth factors FGF, EGF, insulin, and nicotinamide were withdrawn from NS medium and
the base medium is supplemented with TGFb (A-D) to enrich differentiating cells for neuronal fates, FCS/Forskolin to enrich for neuro-glial fates (E–
H) and BMP2 to enrich for smooth muscle (I–L). A, E and I show GFAP immunohistochemistry (green, astrocytes). B, F and J indicate bIII tubulin
(green, immature neurons). C, G and K show nestin (red, neuroblasts) and D, H and L show SMA reactivity (green, smooth muscle actin). Cell nuclei
were visualized by DAPI, bars in A–L represent 100 mm. (M,N) Chondrocytic differentiation can be directed in emNCSC cultures (see materials and
methods for details) and cryosectioned pellets reveal collagen II by Alcian blue staining. Scale bars 100 mM in M and 25 mM in N.
doi:10.1371/journal.pone.0013890.g007
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and differentiating into neurofilament-positive cells (presumably
enteric neurons).
In ovo transplantation of emNCSCs
Finally, we investigated the developmental potential of
emNCSCs, namely, their ability to migrate, integrate and
differentiate in vivo. GFP-labeled emNCSCs were injected into
the chick embryo NC migration pathway beside the midbrain
and rhombomeres 1 and 2 during the endogenous cranial NC
migration (Figure 12A), and assayed for migration, appropriate
targeting and differentiation. Cells were identified using
immunohistochemistry of human nuclear antigen and markers
for terminal differentiation. Five days after injection, trans-
planted cells were found in many of the destinations of cranial
NC such as the branchial arches, the cranial ganglia and the
head mesenchyme. Transplanted cells that migrated from the
graft into the mesenchyme lost expression of HNK-1
(Figure 12B) and contributed to a variety of NC-derived tissues,
both neural and mesenchymal. Some transplanted cells
remained at the graft site and expressed low levels of HNK-1
but no neuronal markers (Figure 12B). Transplanted cells
located throughout the cranial mesenchyme and along skeletal
muscle fibers have elongated nuclei and expressed HNK-1, in
this context, characteristic of Schwann cells (Figure 12C, E, H).
Some transplanted cells were observed in undifferentiated
cranial mesenchyme (Figure 12A, G), and among skeletal
muscle fibers, potentially forming connective tissue. Many
transplanted cells were located around blood vessels, some of
which were positive for SMA (Figure 12D). emNCSCs were also
seen differentiating into smooth muscle in other appropriate
locations (Figure 12H). Numerous transplanted cells were found
in the trigeminal and ciliary ganglia (Figure 12B and F), some of
which expressed neuronal markers (Figure 12F) while others
displayed glial morphology.
Both the location and the differentiation fates of transplanted
cells were appropriate for cells of NC origin. In contrast, we failed
to observe emNCSCs differentiating into cell types not normally
derived from endogenous NC, such as neurons in the CNS. We
concluded that emNCSCs transplanted in chick embryos during
cranial NC migration respond to developmental cues, migrate
along endogenous NC cells and differentiate into the appropriate
tissues/structures.
Discussion
Here, we characterize a population of cells emigrating from
hESC-derived adherent neurospheres plated on fibronectin and
provide evidence that they mimic the dorsal neural tube
containing premigratory NCSCs and resembling their site of
origin in vivo. The adherent neurospheres are mainly composed of
neuroepithelial rosettes, which express Pax3 and Sox9, markers of
dorsal neuroepithelium and premigratory NC [55,56,57], but are
negative for the ventral neural tube marker Nkx2.2 [58]. Cells that
leave neuroepithelial clusters and start migrating on fibronectin
uniformly upregulate Sox10, a critical transcription factor for NC
development [22] (Figure 13). The clusters remain negative for
Sox10 and can be mechanically isolated. After replating on
fibronectin, they give rise to a second wave of emigrating cells,
which also upregulate Sox10. Most of the cells within replated
clusters remain negative for Sox10 3 days after replating. It is likely
that virtually all cells within the original adherent neurospheres are
competent to emigrate and upregulate Sox10. Indeed, over 80%
of cells within adherent neurospheres are positive for the markers
of dorsal neuroepithelium and lack the ventral markers, consistent
with the cells being premigratory NC.
Figure 8. Clonal analysis of emNCSC. Representative examples of multipotent (A–C), bi-potent (F), and unipotent (D, E) clones of emNCSC. For
all images: TuJ1 (green), SMA (red), GFAP (blue); Scale bars 50 mM.
doi:10.1371/journal.pone.0013890.g008
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Analysis of global gene expression profile of cells within the
clusters and emNCSCs revealed selective upregulation of the NC-
related genes in the migratory cells. For example, homeobox gene
PhOX2b is essential for the development of both autonomic and
sympathetic neurons [59,60] and regulates the dynamic expression
of RGS4 [61]. The upregulation of DLK1 and HEY1 in emNCSCs
is consistent with the role of Notch signaling in NC differentiation
and maintenance [62]. We detected selective upregulation of
gonadotropin-releasing hormone 2 (GnRH2) in emNCSCs.
Indeed, some cells releasing GnRH arise from cranial NC [63]
and their differentiation is modulated by the NC transcription
factors SOX10 and FOXD3 [64]. It is tempting to speculate that
these differences between the migratory cells and adherent clusters
will provide insight into the genes and pathways involved in
delamination of human NC.
In contrast to previous reports [15], a much larger fraction
(,100-fold increase) of emNCSCs is positive for the mesenchymal
cell marker CD73, which is a unique characteristic of cephalic
NC. Cephalic NC cells are known to emigrate earlier than trunk
NC in all species studied, including recently derived human NC
cells [40]. Previously described NCSCs lack the expression of
connexin 43 ([15] supplementary microarray data), which could
be due to the extensive passaging. In contrast, the emNCSCs
described in this study uniformly express connexin 43, previously
Figure 9. NC competency is ablated by treatment with Noggin or DKK. The effect of Noggin (BMP inhibitor) and DKK (Wnt inhibitor) on
hESC-derived emNCSCs. Untreated (control) neurosphere cultures are strongly reactive for (A) SOX10 (green), (B) HNK-1 (green), and (C) p75 (red) and
negative for the CNS marker (D) Olig2 (red). The addition of Noggin to NS medium ablates (E) SOX10 (green), (F) HNK-1 (green), and (G) p75 (red) and
induces expression of the CNS marker (H) Olig2 (red). Culturing neurospheres from day 0 in media that was collected from 293T cells transfected with
a DKK plasmid ablates expression of the NC markers (I) SOX10 and (J) HNK-1 while the low affinity neutrophin receptor (K) p75 was still expressed.
The insets in upper left corners show the cell nuclei (DAPI). Scale bars represent 50 mm in A, and C–H, 10 mm in B, and 100 mm in I–K.
doi:10.1371/journal.pone.0013890.g009
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found to be characteristic of early migrating NC [44]. Finally,
previous studies in chick demonstrated that BMP inhibition (e.g.,
with Noggin) can block NC specification during early, but not late
stages of NC development [23]. Treatment with Noggin
quantitatively abolishes the appearance of emNCSCs. Taken
together these data strongly argue that we have identified and
characterized early migratory NCSCs, likely resembling cephalic
NCSCs, derived from human ES cells.
EmNCSCs express the classical marker of NCSC, p75;
however, we found that in our setting, dorsal neuroepithelium-
like cells also express p75. Similarly, both cell types are positive for
HNK-1, a well-known NC marker in avian but not murine
embryos [47]. Indeed, at the time of NC emigration in mice the
most dorsal part of the neural tube, including some premigratory
NC cells residing in that area, are positive for p75 [39]. Similarly,
human neural tube cells express p75 [40]. Previously, when hESCs
were neuralized using stromal feeder cells [15,16], only a
proportion of cells in culture (e.g., the most outer part of
neuroepithelieal rosettes) were found positive for both p75 and
HNK-1 [15]. The difference in the neuralization protocols is a
likely explanation for the observed discrepancies. The heteroge-
neous p75 reactivity within neuroepithelial clusters was observed
Figure 10. CD73 expression in emNCSCs. Early migratory NC cells are considered to be a uniform population of cells capable of differentiation
into mesenchymal and PNS derivatives. To evaluate the potential of hESC-derived emNCSCs the mesenchymal marker CD73 was investigated at
several time points, followed by prospective isolation and differentiation. (A) Day 5 neurospheres were tested for CD73 expression, approximately
0.11% of cells were positive. (B) Adherent neuroepithelial clusters were mechanically separated from migrating cells and tested for CD73 expression,
approximately 0.5% of adherent neuroepithelial rosettes cells were positive. (C) 13% of cells migrating from neuroepithelial rosettes (SOX10-positive
cells) are positive for CD73. (D) Migrating cells were sorted based on CD73 expression and cultured for 1 week. Both CD73-positive and -negative cells
yielded nestin- and SMA-positive cells (areas with abundant staining are shown), however, the MAP2 reactive cells were enriched 10-fold in the CD73-
negative fraction. Both populations had rare GFAP-positive cells and scattered KI67-positive cells. Scale bars represent 10 mm in I, I9 and V9, 50 mm in
III, IV, III9 and IV9, and 100 mm in II, V and II9.
doi:10.1371/journal.pone.0013890.g010
Human Neural Crest Stem Cells
PLoS ONE | www.plosone.org 13 November 2010 | Volume 5 | Issue 11 | e13890
using three different antibodies; rabbit polyclonal serum and two
mouse monoclonal antibodies (including one directly conjugated,
previously used for isolation of human NCSCs [16].) For HNK-1
staining, we used the same monoclonal antibody staining
conditions as previously reported [15].
Recent evidence in avian embryos suggests that the onset of NC
specification occurs during gastrulation, where epiblast cells that
express the transcription factor Pax7, are specified to form NC
cells in the absence of exogenous factors but in a manner that
requires Pax7 itself [19]. In the mouse NC, the Pax3 protein may
be functionally equivalent to the Pax7 [46]. We observed early and
robust upregulation of Pax3 during hESC neutralization, such that
by day 5 of neuralization ,80% of cells were positive for Pax3.
Remarkably nearly 60% of the cells were positive for Sox9, a
marker of premigratory NCSCs. These findings suggest that under
current neuralization conditions most neural progenitors express
markers associated with NC competence and specification.
Despite their early specification at gastrula stages, NC cells do
not delaminate from the neural tube until late neurulation and do
not initiate differentiation until late migratory and post-migratory
stages. Furthermore, execution of NC cell fates in vivo requires
continuous Wnt signaling [65] while various growth factors appear
to direct differentiation along distinct pathways [49,66]. Wnts and
BMPs mediate NC induction in several model species [6,65,67]. In
a previous study using human cells, melanocytes were generated
from hESCs using Wnt3a-conditioned media; however the
presence of multipotent NCSCs was not demonstrated [68].
Indeed, microarray analysis of neurosphere cultures confirmed the
upregulation of Wnt1, Wnt3a, BMP4 and BMP5, as well as the
expression of transcription factors downstream of Wnt and BMP
signaling. EmNCSCs expressed several transcription factors
characteristic of early NC specification in chick, mouse, and
Xenopus. For instance, MSX1 and ZIC1, two of the earliest NC
genes, were upregulated 48 and 72 hours, respectively, after the
start of neuralization. These two genes have been demonstrated to
be pivotal in the development of the NC and the expression of
later NC-specific genes [55,69,70,71]. The later NC-specifying
genes include Sox9, Sox10 and Snail, which proceed to regulate the
EMT and migration of NC cells from the neural tube [70,72,73].
Consistent with these data, expression of Sox9, Sox10 and SNAIL
was upregulated during neuralization of hESCs. The chronolog-
ical order of upregulation of some NC genes in the hESC cultures
may follow a different timetable compared to known in vivomodels;
whether this is due to an in vitro artifact or reflects species
differences remains to be determined.
In vivo, the NC competency zone (area around the neuroecto-
derm border) is mediated by BMP and Wnt signaling with
additional signals, including Wnts mediating the induction of the
NC [52,53,74] and delamination of NC from the neural tube
[75,76]. Different from our approach, most protocols for human
NC derivation from ES cells use exogenous BMP to facilitate the
differentiation [12,15,77]. To test if BMP pathway is also
important for the generation of emNCSCs, we treated neuro-
sphere cultures with Noggin. After treatment with Noggin, the
expression of NC markers Sox10, p75 and HNK-1 was nearly
ablated compared to controls. Treatment with the Wnt/b-catenin
antagonist Dkk1 resulted in the ablation of Sox10 and HNK1, but
not p75. These results are consistent with the distinct mechanisms
of action of Noggin and Dkk1. While Noggin (produced by the
notochord in vivo) re-specifies the dorsal neuroepithelium into
Figure 11. Injection of emNCSCs in aganglionic bowels in ex vivo organotypic cultures. EmNCSCs can colonize aganglionic guts in
organotypic gut cultures and differentiate into neurons. (A) Confocal image of a cryosectioned Ret KO gut segment 7 days post injection labeled with
fluorescent antibodies against neurofilament (red). (B) Non-injected Ret KO gut segment 7 days post injection showing no neurofilament (red)
reactivity. (C) In heterozygous animals endogenous neurons are present in the non-injected gut cultures (neurofilament staining in red). Cell nuclei
are visualized by DAPI. Scale bars in A-C,10 mm. (D) Whole mount of a Ret KO gut segment stained with a neurofilament marker (red) and anti-GFP
expressed by emNCSC (green). The GFP staining overlaps with the neurofilament staining in several places showing emNCSC-derived neurons; one
example is marked by asterisk. Single channels (red, neurofilament and green, GFP) are depicted on top of the merged photograph for better
identification (Magnification 20x).
doi:10.1371/journal.pone.0013890.g011
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ventral fates, Dkk1 inhibits the early steps of NC induction,
without altering the axial cell fates or general patterning [53]. In
our hands, the dorsal neuroepithelium-like clusters (adherent
neurspheres) are positive for p75. The loss of Sox10 and p75 after
the addition of Noggin is consistent with re-specification of dorsal
neuroepithelium into ventral neuroepithelium, which typically
does not express NC markers. Following the same logic, the
addition of Dkk1 may inhibit the NC specification, i.e. appearance
of Sox10- and HNK-1-positive emNCSCs, but does not re-specify
the dorsal neuroepithelium-like cells, which remain positive for
p75. Indeed, the human neural tube cells were found positive for
the p75 antigen at the time when the NC is generated [40]. It
Figure 12. Injection of emNCSCs into the cranial NC pathway of chick embryos. (A) Whole mount view of a clump of grafted emNCSCs
(arrow) injected into the cranial region of a stage 11 chick embryo. (B–H) Sections through the cranial region of chick embryos 5 days post-injection
labeled with fluorescent antibodies to human nuclei (HuN, green), HNK-1 (blue), neuronal marker HuC/HuD (purple) and smooth muscle actin (SMA,
red). (B) A number of human emNCSCs remain clustered and express HNK-1 (arrows) while individual cells that have left the graft site (arrowheads)
are negative for HNK-1 and contribute to head mesenchyme. (C) emNCSCs along HNK-1-positive nerves (arrowheads). (D) SMA-positive (arrow) and
-negative (arrowhead) emNCSCs around a blood vessel. (E) HNK-1-positive emNCSCs within skeletal muscle (arrowhead) do not express muscle actin
(red). (F) Some emNCSCs (arrows, left and right panels) in the TG express the neuronal marker HuC/HuD (middle and right panels). (G) emNCSCs in
undifferentiated mesenchyme near blood vessels around the perimeter of the midbrain. No emNCSCs were observed in the midbrain. (H)
Differentiated emNCSCs (left and right panels) expressing SMA (arrow, middle and right panels) or HNK-1 (arrowhead, middle and right panels). BV -
blood vessel; TG – trigeminal ganglion. Scale bars 200 mM in A, 100 mM in B, 20 mM in C–H.
doi:10.1371/journal.pone.0013890.g012
Figure 13. Scheme of early emNCSCs derivation from hESCs and differentiation into NC lineages. hESC clusters are suspended for 5 days
in NS medium. On day 5 of suspension culture neurospheres were allowed to adhere on fibronectin-coated plates and cultured in NS medium for 3
more days. Adherent neurospheres composed of neuroepithelial rosettes are negative for Sox10 and CD73. Migrating cells are positive for the NC
markers Sox10 and CD73 (13%). Both cell types are positive for p75 and HNK-1. Rosettes can be manually excised and replated (dotted arrow) to yield
additional waves of Sox10-positive emNCSCs. The adherent rosettes are therefore competent to become NC after they have undergone the EMT.
Migratory emNCSCs can be allowed to spontaneously acquire NC lineage fates or can be directed to enrich for certain cell fates by the addition of
growth factors.
doi:10.1371/journal.pone.0013890.g013
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remains to be determined if this expression is localized to the
premigratory neural crest in the dorsal part of human neural tube.
In addition to the patterning growth factors discussed above,
matrix elasticity may affect hESC differentiation towards NC
lineages, similar to that seen for muscle differentiation [78,79]. It
will be important to investigate hESC differentiation into
emNCSC using various elasticity matrixes.
Finally, we assessed the ability of emNCSCs to migrate in vivo,
incorporate into NC derivatives and differentiate appropriately.
Grafted emNCSCs efficiently contributed to a variety of NC-
derived tissues and differentiated appropriately. This finding
demonstrates that emNCSCs are competent to contributing to
NC derivatives such as the trigeminal ganglia, as cells that do not
normally incorporate into the trigeminal ganglia are excluded
from the developing ganglia even when they are immediately
adjacent to it [80]. Furthermore, emNCSCs contributed to
connective tissues including smooth muscle. Therefore, emNCSCs
are capable of extensive migration to appropriate NC cell
destinations and appear to have the ability to interact with
adjacent host NC cells and differentiate efficiently compared to
late emNCSCs, in vivo [15]. Critically, transplanted human
emNCSCs do not contribute to the non-NC cell types, such as
CNS tissue (e.g., midbrain).
Given the fact that these cells are derived in an antigen free
environment (no co-culture with murine tissue) the protocol for the
derivation of emNCSCs is ideal for generating emNCSC-derived
tissues in the culture dish that can subsequently be used for patient
treatment (e.g., neurocristopahties). To determine the therapeutic
potential of these cells for treating a disease model, we investigated
the ability of emNCSCs to colonize aganglionic embryonic guts in
organotypic cultures. EmNCSCs were found to be capable of
colonizing aganglionic guts and differentiating into neurofilament-
positive cells, presumably enteric neurons, in ex vivo gut cultures.
This suggests that emNCSCs might be useful in cell replacement
therapies to treat neurocristopathies.
Supporting Information
Figure S1 Molecular characterization of hESC neuralization.
(A–D) Microarray profiles of hESC derived neruospheres over a
10-day (240 hour) time period. Markers are indicated in the figure.
Y-axis shows the fold increase, X-axis shows the time (hours). (E)
The Q-PCR profile for Pax3 induction, X-axis shows hours of
induction (0-144), Y-axis indicates fold increase of Pax3.
Found at: doi:10.1371/journal.pone.0013890.s001 (0.12 MB TIF)
Figure S2 Spontaneously differentiated emNCSC cultures.
Spontaneously differentiated emNCSC cultures yield a mix of
cell types: (A) SMA (green), Peripherin (red), (B) GFAP (green),
and MAP2 (red) positive cells, (C) GFAP (red), and HNK1 (green)
positive cells.
Found at: doi:10.1371/journal.pone.0013890.s002 (0.70 MB TIF)
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